Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 November 1995 | Volume 123 Issue 9 | Pages 641-648
Objective: To establish human immunodeficiency virus type 1 (HIV-1) messenger RNA (mRNA) expression in peripheral blood mononuclear cells as a marker of risk for progression to the acquired immunodeficiency syndrome (AIDS) in a large cohort of HIV-infected persons followed for a prolonged period.
Design: Retrospective testing of cryopreserved, coded specimens.
Setting: Research laboratories at the New York Blood Center and the Rockefeller University.
Patients: 150 homosexual men infected with HIV-1 who did not have an AIDS diagnosis at the time of testing.
Measurements: Multiply spliced and unspliced HIV-1 mRNAs in total peripheral blood mononuclear cell RNA were quantitated using reverse transcriptase-initiated polymerase chain reaction (PCR) and compared with other laboratory data and clinical outcome during the subsequent 8 years.
Results: Although HIV-1 mRNA expression generally correlated with immunologic status, it was associated with future disease progression independently of CD4+ cell counts or their rate of decrease at the time of sampling. The association of HIV-1 mRNA with disease progression in persons with CD4+ cell counts higher than the median (> 624 cells/mm3) was particularly noteworthy; further variation in the CD4+ cell counts within this group was not prognostically significant.
Conclusions: The expression of HIV-1 mRNA in peripheral blood mononuclear cells is a strong independent marker for future HIV disease progression, even in persons with normal T-cell subsets.
Author and Article Information
From the Rockefeller University and the New York Blood Center, New York, New York; and the Massachusetts Institute of Technology, Cambridge, Massachusetts.
ARTICLE
HIV-1 Messenger RNA in Peripheral Blood Mononuclear Cells as an Early Marker of Risk for Progression to AIDS
![]()
Grant Support: In part by grant A122346 from the National Institutes of Health (Dr. Baltimore) and the Aaron Diamond Foundation for AIDS research (Dr. Saksela).
Requests for Reprints: Kalle Saksela, MD, PhD, The Rockefeller University, Box 285, 1230 York Avenue, New York, NY 10021.
Current Author Addresses: Dr. Saksela: The Rockefeller University, Box 285, 1230 York Avenue, New York, NY 10021.
Related articles in Annals:
This article has been cited by other articles:
![]() |
L. G. Kostrikis, G. Touloumi, R. Karanicolas, N. Pantazis, C. Anastassopoulou, A. Karafoulidou, J. J. Goedert, and A. Hatzakis Quantitation of Human Immunodeficiency Virus Type 1 DNA Forms with the Second Template Switch in Peripheral Blood Cells Predicts Disease Progression Independently of Plasma RNA Load J. Virol., September 11, 2002; 76(20): 10099 - 10108. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zhu, D. Muthui, S. Holte, D. Nickle, F. Feng, S. Brodie, Y. Hwangbo, J. I. Mullins, and L. Corey Evidence for Human Immunodeficiency Virus Type 1 Replication In Vivo in CD14+ Monocytes and Its Potential Role as a Source of Virus in Patients on Highly Active Antiretroviral Therapy J. Virol., January 15, 2002; 76(2): 707 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Lewin, M. Vesanen, L. Kostrikis, A. Hurley, M. Duran, L. Zhang, D. D. Ho, and M. Markowitz Use of Real-Time PCR and Molecular Beacons To Detect Virus Replication in Human Immunodeficiency Virus Type 1-Infected Individuals on Prolonged Effective Antiretroviral Therapy J. Virol., July 1, 1999; 73(7): 6099 - 6103. [Abstract] [Full Text] |
||||
![]() |
R. Sun, J. Ku, H. Jayakar, J.-C. Kuo, D. Brambilla, S. Herman, M. Rosenstraus, and J. Spadoro Ultrasensitive Reverse Transcription-PCR Assay for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma J. Clin. Microbiol., October 1, 1998; 36(10): 2964 - 2969. [Abstract] [Full Text] |
||||
![]() |
A. M. Macher and E. P. Goosby Primary HIV Infection/Acute Retroviral Syndrome: An Intervention Opportunity for Correctional Facilities Journal of Correctional Health Care, April 1, 1998; 5(1): 51 - 62. [Abstract] [PDF] |
||||
![]() |
Y.-W. Tang, G. W. Procop, and D. H. Persing Molecular diagnostics of infectious diseases Clin. Chem., November 1, 1997; 43(11): 2021 - 2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
HIV RNA and Prognosis AIDS Clinical Care, January 1, 1996; 1996(101): 4 - 4. [Full Text] |
||||